Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2005
08/25/2005US20050187151 administering polypeptide to target cells selected from bacteria, yeast and fungi, as antigrowth agents; peptide antibiotics
08/25/2005US20050187150 mimics the binding of heparin and heparan sulfate to the fibroblast growth factor (FGF) ligand and receptor; ternary complex of:an FGF ligand polypeptide; an FGF receptor polypeptide; and a heparin agonist or antagonist
08/25/2005US20050187149 Antitumor agent
08/25/2005US20050187148 Antitumor agent
08/25/2005US20050187147 Compositions and methods for increasing drug efficiency
08/25/2005US20050187145 template-fixed beta -hairpin peptidomimetics incorporating a template-fixed chain of 7 or 11 alpha -amino acid residues which, depending on their position in the chain, are Gly, or Pro, or of certain types; inhibitors of various serine proteases such as trypsin, human cathepsin G, and thrombin
08/25/2005US20050187144 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
08/25/2005US20050187143 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 04% by weight of zinc based on the insulin content of the formulation.
08/25/2005US20050187142 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.4% by weight of zinc based on the insulin content of the formulation.
08/25/2005US20050187140 Implanting a spinal implant by infiltrating a tissue of a host near the implant with an antifibrotic agent, and/or an antiinfective agent and/or a polymer; prevention of surgical adhesions
08/25/2005US20050187139 Prevent mammals tissue injuries
08/25/2005US20050187138 analogs in which one or more amino acids is replaced by a diaza- or triazacyclohexenone, or by an aza-, diaza-, or triazacyclohexenone that is substituted at the alpha -position with a side chain of an amino acid, display an improved ability to assume a beta -strand conformation
08/25/2005US20050186668 Hormonally up-regulated, neu-tumor-associated kinase
08/25/2005US20050186667 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186662 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/25/2005US20050186658 Chimeric metabotropic glutamate receptors and uses thereof
08/25/2005US20050186657 Glycoprotein synthesis
08/25/2005US20050186656 Glycoprotein synthesis
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186649 Inhibitors of human plasmin derived from the kunitz domains
08/25/2005US20050186644 Contacting a sample comprising bladder cells taken from the subject with an antibody that specifically binds to nuclear matrix protein BLCA-4, wherein bladder cancer or risk of developing bladder cancer is indicated if sample contains nuclear matrix protein BLCA-4
08/25/2005US20050186637 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders
08/25/2005US20050186628 Dorsalin-1 polypeptide and uses thereof
08/25/2005US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
08/25/2005US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/25/2005US20050186615 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding
08/25/2005US20050186608 Therapeutic polypeptide recovered from mammalian milk for diagnosis, prevention and treatment of insulin resistance, cardiovascular and hypotensive disorders
08/25/2005US20050186600 Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same
08/25/2005US20050186594 Antisense oligonucleotides for controlling G protein-coupled receptor kinase 6 and use in the treatment and prevention of rheumatoid arthritis, drug addiction, hypertension, reproductive and blood disorders
08/25/2005US20050186593 Cloning and recombinant production of CRF receptor(s)
08/25/2005US20050186575 Corona-virus-like particles comprising functionally deleted genomes
08/25/2005US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity
08/25/2005US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression
08/25/2005US20050186558 Adenocarcinomal cells for expression of whey protein and/or caseinoglycomacropeptide for use in treatment of diabetes
08/25/2005US20050186526 Methods and systems for enabling and stabilizing tooth movement
08/25/2005US20050186287 Use of copper agonists such as divalent metal ions, oligopeptides, oligonucleotides, oligosaccharides, nucleotide analogs that bind to copper binding site of amyloid precursor protein and reduce or prevent release of amyloid A beta peptide; prevention or treatment of Alzheimer's disease
08/25/2005US20050186280 Carbopol" carboxy vinyl polymer stabilizer; topical formulations for eyes or skin; cream, ointment, gel, patches; drugs, cosmetics
08/25/2005US20050186278 Gastroprotected formulations containing alph-amylase inhibitors
08/25/2005US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/25/2005US20050186260 Medicated gel foam and method of use
08/25/2005US20050186247 Such as silk, which induce a fibrotic response in the surrounding tissue such that the device is anchored in situ and its performance is enhanced; prosthetic joint for example
08/25/2005US20050186246 To inhibit scarring when the implant is placed within an animal; e.g. nasal reconstruction or cosmetic implant; antiscarring agent e.g. a taxane
08/25/2005US20050186245 Implantable sensors and implantable pumps and anti-scarring agents
08/25/2005US20050186244 Polymer compositions and methods for their use
08/25/2005US20050186243 Implantable catheter for lumen of a blood vessel; a stent, stent graft, covered stent, aneurysm coil, embolic agent, drug delivery catheter or balloon; drug coated or impregnated; adhesion; self-expandable
08/25/2005US20050186242 Intravascular devices and fibrosis-inducing agents
08/25/2005US20050186239 Implantable sensors and implantable pumps and anti-scarring agents
08/25/2005US20050186220 derived from canine distemper virus; vaccines for inducing immune response
08/25/2005US20050186210 Method for tissue regeneration
08/25/2005US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide
08/25/2005US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone
08/25/2005US20050186202 Mouse-human chimeric variants of CC49 with minimal murine content in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present
08/25/2005US20050186197 Peptide inhibitors of beta lactamases
08/25/2005US20050186190 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2005US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
08/25/2005US20050186179 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
08/25/2005US20050186178 Adenoviral nucleic acid backbone, a heterologous coding sequence encoding granulocyte-macrophage colony stimulating factor
08/25/2005US20050186177 Liquid interferon-beta formulations
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/25/2005US20050186175 such as etanercept and said ester anticholinergic e.g. scopine 2,2-diphenylpropionic acid ester methobromide; treating inflammatory or obstructive respiratory system disorders such as asthma or chronic obstructive pulmonary disease (COPD); inhalants
08/25/2005US20050186174 Compositions comprising two different populations of polymer-active agent conjugates
08/25/2005US20050186168 Skin remodeling and regenerative compositions containing elastin peptide ligands having the amino acid sequence (XGXXPG)n
08/25/2005US20050186146 Interleukin-13 antagonist powders, spray-dried particles, and methods
08/25/2005US20050186145 such as etanercept and said ester anticholinergic e.g. scopine 9-methyl-fluorene-9-carboxylate methobromide; treating inflammatory or obstructive respiratory system disorders such as asthma or chronic obstructive pulmonary disease (COPD); inhalants
08/25/2005US20050186143 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
08/25/2005US20050185135 Electro-active spectacle employing modal liquid crystal lenses
08/25/2005US20050183731 Polymer compositions and methods for their use
08/25/2005US20050183728 Medical implants and anti-scarring agents
08/25/2005DE102004007032A1 Antisense oligonucleotides hybridizing with mRNA or a gene sequence to code structures inhibiting skin or hair pigmentation act in melanine synthesis, expression of melanosome structures and/or melanosome transfer
08/25/2005CA2849552A1 Hybrid polypeptides with selectable properties
08/25/2005CA2559359A1 Identification of snps associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism
08/25/2005CA2556739A1 Pharmaceutical composition for treatment of immunological disorders
08/25/2005CA2556266A1 Use of luteinizing hormone (lh), and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
08/25/2005CA2556245A1 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
08/25/2005CA2556096A1 Use of acrylic-acid based polymers to treat and prevent inflammatory skin conditions
08/25/2005CA2555789A1 Ctgf as target for the therapy of diabetic nephropathy
08/25/2005CA2555393A1 Hybrid proteins of active-site serine beta-lactamase
08/25/2005CA2555274A1 Chimeric vegf peptides
08/25/2005CA2555145A1 Diagnosis and therapeutics for cancer
08/25/2005CA2555142A1 Cell proliferation associated with ccx ckr expression
08/25/2005CA2554999A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
08/25/2005CA2554973A1 Particles for inhalation rapid release properties
08/25/2005CA2554971A1 Methods of diagnosing and treating pre-eclampsia or eclampsia
08/25/2005CA2554380A1 Mecp2e1 gene
08/25/2005CA2554212A1 Rna interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional sina)
08/25/2005CA2552638A1 Protease inhibitors for the treatment of digestive pathologies
08/25/2005CA2549432A1 Lipid rafts and clostridial toxins
08/24/2005EP1566636A1 Use of Tweak modulators and inhibitors for the treatment of neurological conditions
08/24/2005EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/24/2005EP1566440A2 Human Interleukin-11 Receptor
08/24/2005EP1566439A1 Preventing or treating obesity
08/24/2005EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
08/24/2005EP1566386A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof
08/24/2005EP1566184A1 Remedy for corneal failure
08/24/2005EP1566183A1 Use of factor XIII for stimulating the perfusion of ischemic tissue
08/24/2005EP1566182A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
1 ... 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 ... 3163